
A significant policy shift is underway in New Jersey as a new law set to take effect in May 2026 will restrict access to certain ADHD medications. This change is expected to impact the availability of commonly prescribed stimulant therapies statewide, including Adderall and Ritalin.
What’s Changing
The new law aims to limit the prescription of ADHD medications to only those cases where patients have undergone thorough, in-person evaluations. This move is designed to curb misuse and ensure that these powerful medications are used appropriately.
New Jersey law aims to curb ADHD medication misuse by requiring in-person evaluations.
Context and Significance
This policy shift reflects a broader concern about the potential for misuse of ADHD medications. By requiring in-person visits for prescriptions, New Jersey hopes to reduce the risk of these medications being used improperly.
This law is a step towards ensuring that ADHD medications are used safely and effectively.
Laura Lurns · Learning Success expert
Implications for Patients and Families
The new requirements may mean that patients and their families will need to plan for more frequent doctor visits. However, this change also underscores the importance of careful diagnosis and monitoring in the treatment of ADHD.
Key takeaways
- New Law: Restricts ADHD medication prescriptions.In-Person Evaluations: Required for prescription.Impact: Expected to affect access to medications like Adderall and Ritalin.
Looking Ahead
As New Jersey implements this new policy, it will be important to watch for its effects on patients, healthcare providers, and the broader community. The goal is to ensure that those who need these medications can access them safely and effectively.
This policy shift underscores the importance of responsible medication use. For parents and educators, being aware of these changes can help in supporting children with ADHD. Consider exploring resources like the Learning Success program for more information on ADHD and learning strategies.
See what All Access gives your childIs your child struggling in school?
Get your free personalized learning roadmap
You describe what you see at home. We turn it into a plan you start this week.
- Answer 5 short questionnaires about what you already notice, 30–45 minutes at your own kitchen table
- Your child sits no test and gets no score: nothing to schedule, nothing for them to dread
- You do the answering, the AI does the writing, and a person reviews it before it reaches you
- Access all 40+ courses instantly: reading, math, focus, processing and more, with new ones added regularly
Why we use AI, plainly: it writes from a knowledge base our team maintains and audits. We work through it line by line and pull anything the evidence stops supporting. The roadmap you get on Tuesday reflects what we corrected on Monday, and a human still reads it before you do.
Your school district must evaluate your child free of charge if you ask in writing, whatever your income and whatever the outcome (US, 34 CFR 300.111 and 300.301(b)). That route takes time and answers a different question than you do. This one starts today, from what you already know.
Your answers stay yours. We do not sell your personal information, and we do not hand identifiable assessment data to outside AI companies to train their models.
A screener is a starting point, not a diagnosis. If your child might need formal accommodations (an IEP or 504 plan), or you suspect a vision, hearing or medical cause, pursue a professional evaluation too. That is the only route to those supports.



